Devices › Implant, corneal, refractive
Device brand name · Corneal inlay
Raindrop Near Vision Inlay: medical device reports filed with FDA
206 reports name it, 2016–2018. Manufacturer given most often on reports: Revision Optics. Product code LQE.
- 206
- device reports naming the brand
- 0% of all MAUDE reports · about 21 a year
- 0
- reports, 12 months to August 2026
- 0 in the 12 months before
- 15.5%
- classified as malfunction
- 10.4% across the product code
- 0%
- classified as death, as reported
- 0 reports · not verified by FDA
206 medical device reports received by FDA name the brand "Raindrop Near Vision Inlay" (corneal inlay); the manufacturer given most often on reports is Revision Optics; received from September 2016 to November 2018. Brand names are as the reporter or manufacturer wrote them, so one product can appear under several spellings.
0 reports arrived in the 12 months to August 2026, and none in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (84.5%) and malfunction (15.5%); across all implant, corneal, refractive reports (product code LQE) death is recorded in 0% and malfunction in 10.4%. Event type is the reporter's classification of the report, not a verified outcome.
The device problems coded most often are device dislodged or dislocated (31.1%), contamination (2.4%) and labelling, instructions for use or training problem (2.4%). The patient problems coded most often are loss of vision, corneal clouding/hazing and visual disturbances. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Reports by month, five years
No report naming Raindrop Near Vision Inlay was received in the five years to August 2026; the latest was received in November 2018.
By year received
Event type and report source
Event type, as classified on the report
Who filed the report
Grey bar: all 335 reports carrying product code LQE. Event type is the filer's classification and is not verified by FDA.
Device problems coded
| Device problem (FDA code) | Reports | Share | Share across product code |
|---|---|---|---|
| Device dislodged or dislocated | 64 | 31.1% | 20.3% |
| Contamination | 5 | 2.4% | 1.5% |
| Labelling, instructions for use or training problem | 5 | 2.4% | 1.5% |
| Biological environmental factor | 4 | 1.9% | 1.2% |
| Malposition of device | 2 | 1% | 1.2% |
| Positioning problem | 2 | 1% | 0.6% |
| Wrinkled | 2 | 1% | 0.9% |
| Device contamination with chemical or other material | 1 | 0.5% | 0.3% |
| Environmental particulates | 1 | 0.5% | 0.3% |
| Material fragmentation | 1 | 0.5% | 0.3% |
FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.
Patient problems coded
| Patient problem (FDA code) | Reports | Share |
|---|---|---|
| Loss of vision | 80 | 38.8% |
| Corneal clouding/hazing | 78 | 37.9% |
| Visual disturbances | 35 | 17% |
| Blurred vision | 17 | 8.3% |
| Halo | 14 | 6.8% |
| Visual impairmentreduced vision | 13 | 6.3% |
| Keratitis | 11 | 5.3% |
| Dry eye(s) | 9 | 4.4% |
| Corneal edema | 8 | 3.9% |
| Corneal scar | 8 | 3.9% |
| Inflammationinflammation | 8 | 3.9% |
| Corneal ulcer | 5 | 2.4% |
| Corneal abrasion | 4 | 1.9% |
| Foreign body sensation in eye | 3 | 1.5% |
| Tissue damage | 3 | 1.5% |
Patient problem codes are present mainly in reports filed since 2019 and are often blank.
In context
| Measure | Raindrop Near Vision Inlay | Product code LQE | All MAUDE reports |
|---|---|---|---|
| Reports | 206 | 335 | 26,136,888 |
| Share of that pool | — | 61.5% | 0% |
| Classified as death, per 1,000 reports | 0 | 0 | 9 |
| Classified as injury | 84.5% | 88.7% | 36.2% |
| Classified as malfunction | 15.5% | 10.4% | 62.3% |
| Filed by the manufacturer | 96.1% | 85.4% | 94.9% |
Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Questions about Raindrop Near Vision Inlay reports
How many FDA reports name Raindrop Near Vision Inlay?
206 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 0 in the latest 12 months.
What kinds of events are reported?
injury (84.5%) and malfunction (15.5%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.
What device problems are coded?
device dislodged or dislocated (31.1%), contamination (2.4%), labelling, instructions for use or training problem (2.4%), biological environmental factor (1.9%) and malposition of device (1%). These are FDA's device problem codes as entered on the report.
Who files these reports?
manufacturer reports (96.1%) and voluntary reports (3.9%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.
Do these reports show that Raindrop Near Vision Inlay was at fault?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."
How do I report a problem with a medical device?
Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.